Eupatilin CAS 22368-21-4

60270

Synonyms: 5,7-Dihydroxy-3′,4′,6-trimethoxyflavone, Eupatilin, Stillen

Download quality specification Eupatilin-CAS-22368-21-4-QS.pdf

50 mg € 60
100 mg € 80
250 mg € 150
500 mg € 270
For bulk quantities contact us at [email protected]
Cat. No. NST-10-163
CAS 22368-21-4
Purity 98% (HPLC)
Appearance Yellow powder
Molecular formula C18H16O7
Molecular weight 344,31
Storage store in a cool & dry place, keep away from strong light and heat

Certificate of analysis available by request to [email protected]

SKU: N/A Categories: ,
Description

Eupatilin: Unveiling the Potential of a Novel Flavonoid

1. Molecular Identity

  • Chemical Name: 5,7-Dihydroxy-3′,4′,6-trimethoxyflavone
  • CAS Number: 22368-21-4
  • Source: Extracted from Artemisia plants, particularly Artemisia argyi

2. Biochemical Significance

Eupatilin is a bioactive flavonoid with a unique molecular structure that contributes to its diverse pharmacological activities. Its ability to modulate various cellular pathways makes it a compound of significant interest in biomedical research.

3. Key Therapeutic Properties

  • Anti-inflammatory: Suppresses inflammatory mediators
  • Gastroprotective: Exhibits potential in treating gastric disorders
  • Anticancer: Demonstrates antiproliferative effects on various cancer cells
  • Antioxidant: Protects cells from oxidative stress

4. Potential Applications

  • Treatment of gastritis and peptic ulcers
  • Cancer therapy research
  • Management of inflammatory disorders
  • Neuroprotective interventions

5. Current Research Focus

Ongoing studies are investigating Eupatilin’s effects on:

  • Gastrointestinal tract disorders
  • Various cancer types and mechanisms
  • Neurodegenerative diseases
  • Metabolic syndrome and related conditions

6. Formulation Challenges and Innovations

Researchers are actively working on:

  • Enhancing bioavailability through novel delivery systems
  • Developing targeted formulations for specific tissues
  • Creating stable, long-lasting preparations

7. Regulatory Considerations

As a naturally derived compound, Eupatilin’s (CAS 22368-21-4) regulatory status is evolving. Ongoing research aims to establish its safety profile and efficacy for potential therapeutic applications.

8. Future Directions

The scientific community anticipates:

  • Advanced clinical trials for specific indications
  • Exploration of synergistic effects with other bioactive compounds
  • Development of semi-synthetic derivatives with enhanced properties

9. Collaborative Opportunities

We invite researchers, pharmaceutical companies, and healthcare professionals to explore the therapeutic potential of Eupatilin. For inquiries, collaborations, or to discuss how Eupatilin can benefit your research or product development, please contact us at [email protected].

Join us in unlocking the potential of Eupatilin – a promising flavonoid at the forefront of natural product research and innovative therapeutic strategies.